Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study.

Brigitte Delemer Thierry Nguyen-Tan-Hon Romain Coriat Denis Smith Franck SchilloIsabelle RaingeardIradj Sobhani Pierre-Luc Etienne Benedicte Decoudier Ségolène Bisot-Locard Alexandre Santos Gerald Raverot Guillaume Cadiot

Published in: Advances in therapy (2020)

The improvement due to the new formulation of Sandostatin LAR® was reported in terms of handling, ease of use and overall nurse satisfaction. The new formulation greatly reduced treatment administration problems associated with the previous formulation, while maintaining low injection site pain and an equivalent safety profile in both indications.

Keyphrases

drug delivery
end stage renal disease
mental health
ejection fraction
healthcare
chronic kidney disease
primary care
chronic pain
peritoneal dialysis
pain management
neuropathic pain
spinal cord injury
patient reported outcomes
replacement therapy